Correction: Dark Horse Consulting Group Welcomes Growth Investment from WestView Capital Partners
October 04, 2022 09:21 ET
|
Dark Horse Consulting Group
Walnut Creek, CA; Boston, MA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group ("DHC"), the leading global consultancy to the cell and gene therapy (“CGT”) industry, and WestView...
Dark Horse Consulting Group Welcomes Growth Investment from WestView Capital Partners
October 04, 2022 08:12 ET
|
Dark Horse Consulting Group
Walnut City, CA; Boston, MA, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Dark Horse Consulting Group ("DHC"), the leading global consultancy to the cell and gene therapy (“CGT”) industry, and WestView Capital...
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Being Granted Marketing Authorization by the European Commission for Upstaza™ - First Disease-Modifying Treatment for AADC Deficiency
July 21, 2022 16:20 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., July 21, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro Congratulates Partner PTC Therapeutics on Receiving Positive CHMP Opinion for Gene Therapy to Treat AADC Deficiency
May 20, 2022 09:29 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 20, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
ClearPoint Neuro to Present Investigational Research and Exhibit at the American Society of Gene & Cell Therapy Annual Meeting in Washington, DC
May 13, 2022 09:25 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., May 13, 2022 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT) (the “Company”), a global therapy-enabling platform company providing navigation and delivery to the...
Senti Bio to Present at the 40th Annual J.P. Morgan Virtual Healthcare Conference
January 06, 2022 08:02 ET
|
Senti Bio
SOUTH SAN FRANCISCO, Calif., Jan. 06, 2022 (GLOBE NEWSWIRE) -- Senti Biosciences, Inc. (“Senti Bio”), a leading Gene Circuit company today announced that Tim Lu, MD, PhD, Chief Executive Officer and...
Senti Bio Adds Prominent Scientific and Industry Leaders to its Scientific Advisory Board
August 17, 2021 08:00 ET
|
Senti Bio
- Members include world-leading experts in fields of immunotherapy drug discovery and development and commercial oncology therapeutics - - Dr. James Collins, a founder of the field of synthetic...
ClearPoint Neuro, Inc. Announces Installation of ClearPoint® 2.0 Software at Mazowiecki Szpital Bródnowski in Poland
June 16, 2021 16:05 ET
|
ClearPoint Neuro, Inc.
SOLANA BEACH, Calif., June 16, 2021 (GLOBE NEWSWIRE) -- ClearPoint Neuro, Inc. (Nasdaq: CLPT), a global therapy-enabling platform company providing navigation and delivery to the brain, today...
Senti Bio to Present Data from CAR-NK Cell Oncology Pipeline at ISCT Annual Meeting
May 25, 2021 08:00 ET
|
Senti Bio
- Senti Bio has designed a scalable process for efficient manufacturing of allogeneic CAR-NK cell pipeline - - Large scale expansion of PBMC-NK cells and UCB-NK cells may provide a scalable source...
Senti Bio Announces Key Leadership Appointments
May 19, 2021 08:00 ET
|
Senti Bio
- Deborah Knobelman, PhD, appointed Chief Financial Officer - - Curt Herberts, MBS, promoted to Chief Operating Officer and Philip Lee, PhD, promoted to Chief Technology Officer - SOUTH SAN...